Artiva Biotherapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Cash & Equivalents	34.25	53.5	102.53	160.92	25.44	1.87
Short-Term Investments	12.31	23.47	-	-	-	-
Cash & Short-Term Investments	46.56	76.97	102.53	160.92	25.44	1.87
Cash Growth	-54.59%	-24.93%	-36.29%	532.51%	1259.08%	-
Accounts Receivable	0.57	1.03	0.53	0.47	-	-
Other Receivables	0.99	0.82	-	-	-	-
Receivables	1.56	1.86	0.53	0.47	-	-
Prepaid Expenses	1.63	0.99	1.62	0.9	0.67	0.09
Total Current Assets	49.75	79.82	104.68	162.29	26.11	1.96
Property, Plant & Equipment	22.74	24.64	27.62	4.08	2.39	2.5
Long-Term Deferred Charges	2.84	-	-	3.17	0.59	-
Other Long-Term Assets	0.59	0.65	0.76	0.39	0.14	0.38
Total Assets	75.91	105.11	133.05	169.93	29.23	4.84
Accounts Payable	0.82	0.61	1.1	1.44	2.15	0.26
Accrued Expenses	6.21	8.02	10.15	10.13	3.16	0.48
Current Portion of Leases	3.79	3.6	3.49	0.43	0.46	0.21
Current Unearned Revenue	-	-	10.89	7.3	-	-
Total Current Liabilities	10.83	12.23	25.63	19.31	5.76	0.94
Long-Term Debt	-	-	-	-	-	5.64
Long-Term Leases	11.98	13.32	15.96	1.31	1.66	1.97
Long-Term Unearned Revenue	-	-	15.64	21.68	-	-
Other Long-Term Liabilities	27.79	25.17	0.12	0.08	5.31	0.25
Total Liabilities	50.6	50.72	57.34	42.37	12.73	8.8
Additional Paid-In Capital	21.9	18.99	11.9	4.95	0.41	0.03
Retained Earnings	-213.12	-181.31	-152.59	-93.8	-21.98	-3.99
Comprehensive Income & Other	0.12	0.31	-	-	-	-
Total Common Equity	-191.1	-162.02	-140.7	-88.86	-21.57	-3.96
Shareholders' Equity	25.32	54.4	75.72	127.56	16.5	-3.96
Total Liabilities & Equity	75.91	105.11	133.05	169.93	29.23	4.84
Total Debt	15.77	16.91	19.45	1.74	2.12	7.82
Net Cash (Debt)	30.79	60.06	83.08	159.18	23.33	-5.95
Net Cash Growth	-62.94%	-27.71%	-47.81%	582.42%	-	-
Net Cash Per Share	38.05	74.81	108.36	232.10	36.94	-9.76
Filing Date Shares Outstanding	24.29	0.81	0.77	0.71	0.73	0.61
Total Common Shares Outstanding	0.81	0.81	0.77	0.71	0.73	0.61
Working Capital	38.92	67.59	79.05	142.98	20.34	1.02
Book Value Per Share	-234.70	-200.07	-183.50	-124.96	-29.71	-6.50
Tangible Book Value	-191.1	-162.02	-140.7	-88.86	-21.57	-3.96
Tangible Book Value Per Share	-234.70	-200.07	-183.50	-124.96	-29.71	-6.50
Machinery	11.62	11.24	-	2.78	0.53	0.25
Leasehold Improvements	0.41	0.39	-	0.04	0.04	0.05

Source: S&P Capital IQ. Standard template. Financial Sources.